MIT Develops Nanoparticles for In-Body Immune Cell Reprogramming

MIT researchers have created nanoparticles that can reprogram immune cells directly within the body to target and eliminate diseased cells. In preclinical mouse experiments, this technique successfully eradicated tumors and reversed liver damage. This breakthrough could simplify and reduce the cost of potent immune therapies, offering new avenues for treating cancers like lymphoma and autoimmune conditions such as autoimmune hepatitis by delivering genetic instructions to natural killer (NK) cells.